Approval · Notice of Compliance 31356 · 2023
FREYA 21: Notice of Compliance 31356
Issued August 2, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31356
- Date
- August 2, 2023
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and Package Insert
- Canadian reference product
- MARVELON 28 (Organon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FREYA 21 | Not yet assigned | — |
| FREYA 28 | Not yet assigned | — |
Medicinal ingredients
- DESOGESTREL 0.15 MG per TAB
- ETHINYL ESTRADIOL 0.03 MG per TAB